April 27th 2025
New research explores the complex relationship between female infertility and gynecological cancers, revealing minimal links and emphasizing the need for further studies.
Dr Rachel Dalthorp: Zuranolone, the First Line of Treatment for Postpartum Depression
July 10th 2024Rachel Dalthorp, MD, explains that zuranolone is recommended as the first-line medication, alongside psychotherapy, to effectively manage postpartum depression (PPD) and mitigate long-term impacts.
Watch
Telehealth Can Drive More Meaningful Serious Illness Conversations in MDS, AML
July 10th 2024Researchers collected feedback from 20 clinicians implementing a telehealth serious illness conversation (SIC) with their patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Read More
VEXAS Syndrome Often Misdiagnosed as Pyoderma Gangrenosum
July 3rd 2024In a recently published systematic review, researchers determined that VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome typically presents in men, with atypical morphology and with systemic symptoms.
Read More
Final Readout of FIREFISH Study Showcases Risdiplam’s Pronounced Effects in Spinal Muscular Atrophy
July 3rd 2024The FIREFISH study showed that most children with type I spinal muscular atrophy (SMA) maintained or improved motor functions and feeding abilities over 5 years when treated with risdiplam.
Read More
Subcutaneous Ofatumumab Shows Reduced Injection Reactions in Multiple Sclerosis
June 28th 2024New findings show a similar number of injective-related reactions (IRRs) were reported between the use of ofatumumab (Kesimpta) and ocrelizumab (Ocrevus) in the treatment of multiple sclerosis, but less severe reactions have been associated with ofatumumab.
Read More